Browsing "School of Medical Sciences" by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 592 to 611 of 2879 < previous   next >
PreviewIssue DateTitleAuthor(s)
2006Cyanobacterial (Blue-Green algal) toxins in water supplies: CylindrospermopsinsFalconer, I.; Humpage, A.
2007The cyanobacterial toxin, cylindrospermopsin, induces fetal toxicity in the mouse after exposure late in gestationRogers, E.; Zehr, R.; Gage, M.; Humpage, A.; Falconer, I.; Marr, M.; Chernoff, N.
2005Cyanobacterial toxins of drinking water supplies - Cylindrospermopsins and microcystinsFalconer, I.
2007Cyanobacterial toxins present in Microcystis aeruginosa extracts - more than microcystins!Falconer, I.
2013Cyanotoxins and their environmental significanceFalconer, I.
2008Cyanotoxins workgroup reportPegram, R.; Humpage, A.; Neilan, B.; Runnegar, M.; Nichols, T.; Thacker, R.; Pflugmacher, S.; Etheridge, S.; Love, A.; ISOC-HAB (2005 : NC, USA)
2000Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoringMorris, R.
2001Cyclosporin monitoring - state of the art?Morris, R.; Russ, G.
2002Cyclosporin monitoring in Australasia: 2002 update of concensus guidelinesMorris, R.; Ilet, K.; Tett, S.; Ray, J.; Fullinfaw, R.; Cooke, R.; Cook, S.
2002Cyclosporin monitoring in Australasia: Survey of laboratory practices in 2000Morris, R.; Lam, A.
2005Cylindrospermopsin genotoxicity and cytotoxicity: Role of cytochrome P-450 and oxidative stressHumpage, A.; Fontaine, F.; Froscio, S.; Burcham, P.; Falconer, I.
2003Cylindrospermopsin occurrence in two German lakes and preliminary assessment of toxicity and toxin production of Cylindrospermopsis raciborskii (Cyanobacteria) isolatesFastner, J.; Heinze, R.; Humpage, A.; Mischke, U.; Eaglesham, G.; Chorus, I.
2003Cylindrospermopsin-induced protein synthesis inhibition and its dissociation from acute toxicity in mouse hepatocytesFroscio, S.; Humpage, A.; Burcham, P.; Falconer, I.
2007CYP2B6 CYP2D6 and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomesDavies, B.; Coller, J.; Somogyi, A.; Milne, R.; Sallustio, B.
2004CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesHutchinson, M.; Menelaou, A.; Foster, D.; Coller, J.; Somogyi, A.
2010CYP2D6 polymorphisms as predictors of outcome in breast cancer patients treated with tamoxifen: Expanded polymorphism coverage improves risk stratificationSchroth, W.; Hamann, U.; Fasching, P.; Dauser, S.; Winter, S.; Eichelbaum, M.; Schwab, M.; Brauch, H.
2004CYP3A4 mediates dextropropoxyphene N-demethylation to nordextropropoxyphene: human in vitro and in vivo studies and lack of CYP2D6 involvementSomogyi, A.; Menelaou, A.; Fullston, S.
2018CYP3A5*3 and ABCB1 61A>G significantly influence dose-adjusted trough blood tacrolimus concentrations in the first three months post-kidney transplantationHu, R.; Barratt, D.; Coller, J.; Sallustio, B.; Somogyi, A.
1998Cytokine dysregulation in the post-Q-fever fatigue syndromePentilla, I.; Harris, R.; Storm, P.; Haynes, D.; Worswick, D.; Marmion, B.
2006Cytokines and mediators in physiologic and pathologic bone resorptionHaynes, D.; Crotti, T.